Company Filing History:
Years Active: 2011
Title: The Innovations of Sarah McQuaid
Introduction
Sarah McQuaid is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. Her work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Sarah McQuaid holds a patent for Amylin Family Polypeptide-6 (AFP-6) analogs and methods of making and using them. This invention relates to AFP-6 analogs, which include derivatives and fragments, as well as related nucleic acids, expression constructs, and host cells. The patent outlines processes for the recombinant production of AFP-6 analogs, which feature one or more amino acid sequence modifications. Additionally, the methods and compositions described in the patent aim to treat and prevent conditions such as metabolic and cardiovascular disorders, including obesity, diabetes, metabolic syndrome, myocardial ischemia, and increased cardiovascular risk.
Career Highlights
Sarah McQuaid is associated with Amylin Pharmaceuticals, Inc., where she has been instrumental in advancing research and development efforts. Her expertise in biotechnology has positioned her as a key player in the industry.
Collaborations
Some of her notable coworkers include Mary Erickson and Ved Srivastava, who have collaborated with her on various projects within the company.
Conclusion
Sarah McQuaid's innovative work in the field of biotechnology exemplifies her commitment to improving health outcomes through scientific advancements. Her contributions continue to have a lasting impact on the industry.